Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending April 10, 2008. The report serves as a notification of transactions involving Directors, Persons Discharging Managerial Responsibility, or Connected Persons regarding their interests in the company's Ordinary shares.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly a regulatory disclosure of share transactions and does not contain financial performance data.
Material Changes
The filing details the acquisition of Ordinary shares by four individuals (Mr. J S Heslop, Mr. E J Gray, Mr. D Learmouth, and Mr. A P Witty) on April 9, 2008. Each individual acquired 12 shares through the personal contribution element and 12 shares through the matching element of the Company's ShareReward Plan. The purchase price was GBP 11.02 per share.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the notification of the specific share transactions described above.
Investor Verification Points
- Verify the share price of GBP 11.02 per Ordinary share on April 9, 2008.
- Confirm the terms of the ShareReward Plan entered into on October 5, 2001.
- Review the total number of shares held by the named directors post-transaction.
- Ensure compliance with Disclosure and Transparency Rule 3.1.4R(1)(a).